Cazac, G.-D.; Lăcătușu, C.-M.; Ștefănescu, G.; Mihai, C.; Grigorescu, E.-D.; Onofriescu, A.; Mihai, B.-M.
Glucagon-like Peptide-1 Receptor Agonists in Patients with Type 2 Diabetes Mellitus and Nonalcoholic Fatty Liver Disease—Current Background, Hopes, and Perspectives. Metabolites 2023, 13, 581.
https://doi.org/10.3390/metabo13050581
AMA Style
Cazac G-D, Lăcătușu C-M, Ștefănescu G, Mihai C, Grigorescu E-D, Onofriescu A, Mihai B-M.
Glucagon-like Peptide-1 Receptor Agonists in Patients with Type 2 Diabetes Mellitus and Nonalcoholic Fatty Liver Disease—Current Background, Hopes, and Perspectives. Metabolites. 2023; 13(5):581.
https://doi.org/10.3390/metabo13050581
Chicago/Turabian Style
Cazac, Georgiana-Diana, Cristina-Mihaela Lăcătușu, Gabriela Ștefănescu, Cătălina Mihai, Elena-Daniela Grigorescu, Alina Onofriescu, and Bogdan-Mircea Mihai.
2023. "Glucagon-like Peptide-1 Receptor Agonists in Patients with Type 2 Diabetes Mellitus and Nonalcoholic Fatty Liver Disease—Current Background, Hopes, and Perspectives" Metabolites 13, no. 5: 581.
https://doi.org/10.3390/metabo13050581
APA Style
Cazac, G.-D., Lăcătușu, C.-M., Ștefănescu, G., Mihai, C., Grigorescu, E.-D., Onofriescu, A., & Mihai, B.-M.
(2023). Glucagon-like Peptide-1 Receptor Agonists in Patients with Type 2 Diabetes Mellitus and Nonalcoholic Fatty Liver Disease—Current Background, Hopes, and Perspectives. Metabolites, 13(5), 581.
https://doi.org/10.3390/metabo13050581
